Drug Profile
DepoTranexamic acid - Pacira BioSciences
Alternative Names: DepoTXALatest Information Update: 14 Oct 2021
Price :
$50
*
At a glance
- Originator Pacira Pharmaceuticals
- Developer Pacira BioSciences
- Class Amines; Anti-infectives; Anti-inflammatories; Antifibrinolytics; Antihaemorrhagics; Cardiovascular therapies; Cyclohexanecarboxylic acids; Nonsteroidal anti-inflammatories; Skin disorder therapies; Small molecules
- Mechanism of Action Antifibrinolytic agents; Plasminogen activator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Surgical blood loss
Most Recent Events
- 01 Dec 2020 Discontinued - Phase-II for Surgical blood loss in USA (Injection) before December 2020
- 09 Apr 2019 Pacira Pharmaceuticals is now called Pacira BioSciences
- 05 Apr 2017 Chemical structure information added